With the annual meeting of the American Society of Clinical Oncology (ASCO) now just days away, multiple large drugmakers have lifted the lid on data that they 29 May 2024
The annual meeting of the American Society of Clinical Oncology (ASCO) is set to commence on 2 June in Chicago, with the highly anticipated plenary session taki 22 May 2024
Swiss cancer giant Novartis and German drugmaker Bayer are among the latest companies to lift the lid on upcoming data presentations at ASCO 2024. 17 May 2024
German drugmaker Bayer will present positive results from the OASIS 1 and 2 studies at the annual meeting of the American College of Obstetricians and Gynecolog 17 May 2024
More leading oncology companies have outlined their planned highlights for the upcoming annual meeting of the American Society of Clinical Oncology (ASCO). 15 May 2024
With the annual meeting of the American Society of Clinical Oncology (ASCO) now only weeks away, more drugmakers and research groups are lifting the lid on data 14 May 2024
Oncology companies including New York-based giant Pfizer (NYSE: PFE) and Japan’s Astellas Pharma (TSE: 4503) have outlined details of data they intend to presen 13 May 2024
Companies including Gilead Sciences unit Kite, as well as Boston-based Treos Bio, have outlined data they intend to present at the upcoming annual meeting of th 9 May 2024
British pharma major AstraZeneca has presented new real-world data from the INFORM and COVIDRIVE real-world studies at the annual meeting of the European Societ 26 April 2024
Connecticut, USA-based biotech company Biohaven has priced an underwritten public offering with the goal of raising approximately $230 million. 19 April 2024
Shares of US biotech Moderna jumped to nearly $108 on Wednesday after the firm revealed encouraging data for its cancer vaccine, mRNA-4157. 11 April 2024
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.